2014 Detroit Regional Conference

2014 Neuroendocrine Tumor Regional Conference
“Multidisciplinary Management of NET Cancers”
Troy, Michigan
May 17, 2014

This forum is designed for physicians and other health professionals from a variety of settings and levels to include the specialties of oncology, endocrinology, surgery, pathology, internal medicine, gastroenterology, nuclear medicine, nursing, nutrition, diagnostic radiology, interventional radiology, and primary care. Leading experts in the field will discuss, through lectures and panel discussions, the different aspects of diagnosis, histopathology, surgery, hepatic directed therapy, and various systemic treatments targeted to specific NET origins. There will be several opportunities for audience questions and networking with faculty.

ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Wayne State University School of Medicine and the North American Neuroendocrine Tumor Society. The Wayne State School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. 

CREDIT DESIGNATION: Wayne State School of Medicine designates this live educational activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EDUCATIONAL OBJECTIVES: At the conclusion of this educational program, participants should be able to:

  • Interpret current advance in the histopathology of both primary and metastatic NETs and how classification determines diagnostic approach, management and prognosis;
  • Utilize the proper assays & diagnostic techniques for identifying and monitoring NET diseases;
  • Describe the various surgical interventions for different NET sites and define the importance of incorporating an evaluation by an experienced NET surgeion into the patient's ongoing treatment plan;
  • Evaluate the safety and efficacy of image guided diagnostics or treatment and determine when to integrate the procedure(s) into the patient's treatment plan; 
  • Specify the risks and benefits of each liver directed therapy based on patient-specific information;
  • Identify the numerous syndromes associated with neuroendocrine tumors and define the symptoms related to each condition;
  • Compare the clinical effectiveness of the different targeted therapies and radiotherapeutic approaches to assess which intervention would be most appropriate for patients with different neuroendocrine tumors;
  • Illustrate the value of creating a multidisciplinary team and communication system to improve the quality of care for NET patients.

DISCLOSURE STATEMENT:  All planners, speakers, authors, reviewers and staff members involved with content development for continuing education activities sponsored by Wayne State University School of Medicine are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.  

TUTION INFORMATION:  Attendees are responsible for all airfare, lodging, and transportation costs. The program fee includes: Catered break, breakfast and lunch and all instructional materials. To ensure enrollment, register and pay online or complete the registration form online, print and mail it with your tuition payment as soon as possible. To help meet administrative costs, a service charge of $25 will be assessed on all refund requests received by May 07, 2014. No refunds can be issued after that date. Should conditions warrant, the sponsors reserve the right to cancel this program with a full tuition refund. Please register early as enrollment will be limited.  If you require special assistance, please contact Kari @ 360.314.4112.


PHYSICIANS/PhD (MD, MD/PhD, PhD, DO, Pharmacy, DVM) - $50.00
Other Medical Professionals (PA, NP, RN, RD, FNP, LSCW) -  $25.00
Others Professionals 
(industry, pharmacy representatives,  allied members) - $25.00
Residents, Fellows, Students 
- $0.00

Please do not include credentials.
Login or Register to receive member benefits
Location of Conference: Detroit Marriott Troy Hotel * 200 West Big Beaver Road * Troy, Michigan  

For Hotel Reservations/Accomodations:  Detroit Marriott Troy Hotel  or  Call: 248.680.9797 or 1.866.539.8117 (use group name – NANETS) Group Rate is $115. 

Saturday – May 17, 2014
7:30 am – 8:15 am    Registration & Breakfast
8:15 am – 8:20 am      Welcome & Introductions – Philip A. Philip
8:20 am – 9:40 am      Presentation and Diagnosis  
        Overview of Carcinoid Tumors and Other NETs – Laura H. Tang
  • General Background & Epidemiology
        Pathology- Laura H. Tang
  • General Features
  • Organ Specific Issues
  • Grading, Staging and Classification
  • Minimum Pathology Data Set
                           Diagnosis of NETs
  • Endoscopy & Colonoscopy – Fadi Antaki
  • Biomarkers: Interpreting Laboratory Results to Clinical Use - Fadi Antaki
  • Obstacles In Diagnosis For the Clinician - Fadi Antaki
  • Radiological Imaging – Selecting the Right Procedure & Contrast Agents - Anthony F. Shields
  • Nuclear Imaging - Which Techniques are Most Efficient for Localizing Tumors? Anthony F. Shields
                                                                 Q & A
          9:40 am – 11:00 am    Surgical Options: Making the Right Choice
                                               Surgical Intervention of NETs
  • Potential for Crisis & Octreotide Protocol – Rodney F. Pommier
  • Surgery for Stomach, Small Bowel, Appendiceal and Rectal NETs - Rodney F. Pommier  
  • Removal of Primary & Mesenteric Nodal Mass - Rodney F. Pommier
  • Surgery for Pancreatic Endocrine Tumors – Steve Kim
  • Resection of Liver Mets & Laparoscopy – Marwan Kazimi
                                                                  Q & A
        11:00 am – 11:15 am    BREAK
        11:15 am – 11:45 am     The Role of Interventional Radiology in the Diagnosis & Management of NETs 
                                                Diagnosis of NETs – Jeffrey J. Critchfield
  • Image guided biopsy
  • CT/Ultrasound/MRI guided treatment
                                                Management of Hepatic Metastases – Jeffrey J. Critchfield
  • Embolotherapy & Ablation
                                                                   Q & A
        11:45 am – 1:00 pm       Management of Hormonal Syndromes from NETs
                                                 Functioning & Non Functioning Pancreatic NETs – David C. Metz
                                                 Carcinoid Syndrome  - Rodney F. Pommier
  • Symptomatic Control (octreotide, lanreotide, pasireotide,telotristat etiprate)
  • Disease Stabilization and Improved Survival (PROMID study)
  • Managing Persistent/Recurrent Diarrhea
  • Carcinoid Heart Disease
                                                                  Q & A
       1:00 pm – 2:00 pm     LUNCH
        2:00 pm – 3:00 pm      Medical Management of NETs
                                               Systemic Therapies
  • Overview Cytotoxic Therapies – Philip A. Philip
  • Clinical Development of VEGF Pathway  & mTOR Inhibitors in NETs - Philip A. Philip
  • Peptide Receptor Radionuclide Therapy –Current Status in US – David C.Metz
  • Other Current Clinical Trials – David C. Metz
                                                                   Q & A

        3:00 pm – 3:45 pm      Developing a Multidisciplinary  Team & Case Presentations  - Philip A. Philip & Panel
                                                                   Q & A